- Home
- EH vs VSTM Comparison
EH vs VSTM Comparison
Compare EH & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EH | VSTM |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 464.9M | 395.4M |
| IPO Year | 2019 | 2011 |
Fundamental Metrics
Financial Performance| Metric | EH | VSTM |
|---|---|---|
| Price | $4.91 | $6.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $22.47 | $16.50 |
| AVG Volume (30 Days) | 1.1M | ★ 3.1M |
| Earning Date | 05-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,914,000.00 |
| Revenue This Year | $33.23 | $282.64 |
| Revenue Next Year | $73.83 | $72.25 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 209.14 |
| 52 Week Low | $4.99 | $3.43 |
| 52 Week High | $20.33 | $11.25 |
Technical Indicators
Market Signals| Indicator | EH | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 29.93 | 66.74 |
| Support Level | N/A | $5.77 |
| Resistance Level | $6.98 | $6.48 |
| Average True Range (ATR) | 0.33 | 0.48 |
| MACD | 0.06 | 0.08 |
| Stochastic Oscillator | 7.62 | 87.28 |
Price Performance
Historical ComparisonAbout EH EHang Holdings Limited ADS
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company focused on autonomous aerial vehicle technology and solutions. The company provides unmanned aerial vehicle (UAV) systems and solutions for air mobility, including passenger transportation and logistics, as well as smart city management and aerial media solutions. Its EH216-S passenger-carrying pilotless eVTOL aircraft has obtained a production certificate and standard airworthiness certificate from the Civil Aviation Administration of China (CAAC).
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.